HBH

82.9

+0.24%↑

HBH

82.9

+0.24%↑

HBH

82.9

+0.24%↑

HBH

82.9

+0.24%↑

HBH

82.9

+0.24%↑

Search

Evonik Industries AG

Fermé

SecteurConsommation cyclique

14.08 1.22

Résumé

Variation du prix de l'action

24h

Actuel

Min

14.04

Max

14.1

Chiffres clés

By Trading Economics

Revenu

-63M

236M

Ventes

-278M

3.5B

P/E

Moyenne du Secteur

15.794

29.124

BPA

0.34

Rendement du dividende

8.05

Marge bénéficiaire

6.745

Employés

31,273

EBITDA

-53M

508M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+25.2% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

8.05%

3.12%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.5B

6.8B

Ouverture précédente

12.86

Clôture précédente

14.08

Sentiment de l'Actualité

By Acuity

25%

75%

38 / 374 Classement par Consumer cyclical

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Evonik Industries AG Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 nov. 2025, 21:06 UTC

Principaux Mouvements du Marché

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 nov. 2025, 18:10 UTC

Résultats

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 nov. 2025, 13:10 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 12:00 UTC

Résultats

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 nov. 2025, 10:30 UTC

Résultats

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 nov. 2025, 03:50 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 22:36 UTC

Résultats

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov. 2025, 22:22 UTC

Résultats

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Net $210M >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q EPS $9.89 >CSU.T

7 nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 nov. 2025, 20:59 UTC

Résultats

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 nov. 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 nov. 2025, 20:22 UTC

Résultats

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 nov. 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 nov. 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 nov. 2025, 19:31 UTC

Market Talk
Acquisitions, Fusions, Rachats

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 nov. 2025, 19:17 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 nov. 2025, 19:09 UTC

Résultats

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 nov. 2025, 19:08 UTC

Résultats

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 nov. 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 nov. 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Comparaison

Variation de prix

Evonik Industries AG prévision

Objectif de Prix

By TipRanks

25.2% hausse

Prévisions sur 12 Mois

Moyen 17.59 EUR  25.2%

Haut 25 EUR

Bas 15 EUR

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

11 ratings

2

Achat

8

Maintien

1

Vente

Score Technique

By Trading Central

19.83 / 20Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

38 / 374Classement par Consommation cyclique

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Evonik Industries AG

Evonik Industries AG produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides additives for polyurethane; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants, and viscosity index improvers for coatings for oil and other lubricants for construction machinery and automotive sector. The Nutrition & Care segment offers D-/l-methionine and lysine for animal nutrition industry; amino acids and peptides; pharmaceutical active ingredients; and biocompatible and bioresorbable materials for orthopedic and medical applications; and system solutions for the cosmetics and detergent industries. The Smart Materials segment provides inorganic materials, including fumed and precipitated silicas and silanes; peroxides for paper and textile industries; specialty catalysts for synthesis and alkoxides; polymers products, such as polymide 12, polymer foam, specialty polybutadiene and polyester, alkoxides, and membranes. The Performance Materials offers C4 derivatives consisting of butadiene, MTBE, butene-1, isononanol, and DINP for use in automotive industry; and superabsorbent products for diapers and hygiene products. The Technology & Infrastructure segment provides energy management, integrated plant support and maintenance, process safety and engineering, pipelines, transport management, logistics safety, digital solutions for chemical production, and strategic site development services. The company was founded in 1873 and is headquartered in Essen, Germany.
help-icon Live chat